Results 31 to 40 of about 9,523 (188)

COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies [PDF]

open access: yes, 2022
We studied COVID-19 vaccination-related adverse events (ADEs) 7-days post-vaccination in patients with idiopathic inflammatory myopathies (IIMs) and other systemic autoimmune and inflammatory disorders (SAIDs)
Selva-O'Callaghan A.   +32 more
core   +1 more source

Case of Polymyositis Associated with Celiac Disease: A Case Report

open access: yesPakistan Armed Forces Medical Journal, 2023
Polymyositis is an important subtype of idiopathic inflammatory myopathies characterized by muscle inflammation andweakness, often associated with other systemic diseases and malignancies.
Abdul Rehman Azeem   +4 more
doaj   +1 more source

Evolving classification and role of muscle biopsy in diagnosis of inflammatory myopathies

open access: yesIndian Journal of Pathology and Microbiology, 2022
Idiopathic inflammatory myopathy (IIM) is a broad term that includes dermatomyositis, polymyositis, overlap myositis, sporadic inclusion body myositis, and immune-mediated necrotizing myopathy.
Meenakshi Swain, Megha Uppin
doaj   +1 more source

Polymyositis and dermatomyositis: Disease spectrum and classification

open access: yesIndian Journal of Dermatology, 2012
Muscle inflammation and weakness are the key features of idiopathic inflammatory myopathies (IIMs). In addition IIMs are frequently associated with cutaneous and pulmonary involvement. In clinical practice the three common inflammatory myopathies we come
Siba P Raychaudhuri, Anupam Mitra
doaj   +1 more source

Management of the idiopathic inflammatory myopathies [PDF]

open access: yes, 2019
The idiopathic inflammatory myopathies (IIMs) – comprising polymyositis, dermatomyositis and inclusion body myositis – are a rare group of disorders characterised by muscle inflammation.
Ashraful Haque   +7 more
core   +1 more source

Clinical characteristics of patients with anti-TIF1-γ antibodies

open access: yesRheumatology, 2016
Objectives : Inflammatory myopathies are a group of idiopathic, heterogeneous systemic diseases affecting predominantly skeletal muscles, though they can also involve the skin and internal organs.
Anna Masiak   +3 more
doaj   +1 more source

Predictors of cardiac involvement in idiopathic inflammatory myopathies

open access: yesFrontiers in Immunology, 2023
ObjectivesIdiopathic inflammatory myopathies (IIM) are a group of rare disorders that can affect the heart. This work aimed to find predictors of cardiac involvement in IIM.MethodsMulticenter, open cohort study, including patients registered in the IIM ...
Matilde Bandeira   +43 more
doaj   +1 more source

POLYMYOSITIS/DERMATOMIOSITIS: DIFFERENTIAL DIAGNOSIS

open access: yesНаучно-практическая ревматология, 2016
The lecture considers the problem of rare systemic connective tissue diseases, such as idiopathic inflammatory myopathies (IIMs). It underlines the clinical and immunological heterogeneity of their subtypes, which defines therapeutic tactics and ...
O. A. Antelava
doaj   +1 more source

Polymyositis and dermatomyositis – challenges in diagnosis and management

open access: yesJournal of Translational Autoimmunity, 2019
Polymyositis (PM) and dermatomyositis (DM) are different disease subtypes of idiopathic inflammatory myopathies (IIMs). The main clinical features of PM and DM include progressive symmetric, predominantly proximal muscle weakness.
Shu-Han Yang   +2 more
doaj   +1 more source

Cardiac Manifestations in Idiopathic Inflammatory Myopathies: An Overview [PDF]

open access: yes, 2019
Idiopathic inflammatory myopathies are a group of autoimmune diseases that are characterized by muscle inflammation resulting in elevated muscle enzyme release and distinctive biopsy findings.
Divya Jayakumar   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy